TRAVERE THERAPEUTICS, INC. Increase (Decrease) Due from Other Related Parties
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) Due from Other Related Parties of $0 for the 3-month period ending 2013-03-31, per its 10-Q/A filed 2013-09-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseDueFromOtherRelatedParties · last filed 2013-09-16
- TRAVERE THERAPEUTICS, INC. increase (decrease) due from other related parties for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) due from other related parties for the quarter ending 2012-06-30 was -$4.75K.
- TRAVERE THERAPEUTICS, INC. increase (decrease) due from other related parties for the quarter ending 2012-03-31 was $198.25K.
| Period end | Increase (Decrease) Due from Other Related Parties 3 month | Increase (Decrease) Due from Other Related Parties 6 month | Increase (Decrease) Due from Other Related Parties 25 month |
|---|---|---|---|
| 2013-03-31 | $0.00 10-Q/A · filed 2013-09-16 | $0.00 10-Q/A · filed 2013-09-16 | |
| 2012-06-30 | -$4.75K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-09-16 | $193.50K 10-Q · filed 2013-09-16 | |
| 2012-03-31 | $198.25K 10-Q/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |